The recombinant nanoparticle protein-based vaccine — NVX-CoV2373 — developed by the American biotechnology firm Novavax, has been branded Covovax in India.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3z3UdPa
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Sites in Pune to start enrolling children for Covovax trial within 2 weeks: SII
https://ift.tt/eA8V8J
No comments:
Post a Comment